A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 672,098 shares of VRTX stock, worth $303 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
672,098
Previous 665,382 1.01%
Holding current value
$303 Million
Previous $312 Million 0.23%
% of portfolio
0.22%
Previous 0.23%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$460.0 - $505.78 $3.09 Million - $3.4 Million
6,716 Added 1.01%
672,098 $313 Million
Q2 2024

Jul 19, 2024

SELL
$392.81 - $485.53 $20.8 Million - $25.7 Million
-53,028 Reduced 7.38%
665,382 $312 Million
Q1 2024

Apr 19, 2024

BUY
$407.69 - $446.08 $3.18 Million - $3.48 Million
7,794 Added 1.1%
718,410 $300 Million
Q4 2023

Jan 30, 2024

SELL
$343.0 - $410.68 $332,024 - $397,538
-968 Reduced 0.14%
710,616 $289 Million
Q3 2023

Oct 30, 2023

SELL
$338.18 - $362.46 $3.54 Million - $3.79 Million
-10,457 Reduced 1.45%
711,584 $247 Million
Q2 2023

Jul 31, 2023

SELL
$314.42 - $351.91 $38.7 Million - $43.4 Million
-123,186 Reduced 14.57%
722,041 $254 Million
Q1 2023

Apr 27, 2023

SELL
$283.23 - $323.1 $2.74 Million - $3.13 Million
-9,681 Reduced 1.13%
845,227 $266 Million
Q4 2022

Jan 30, 2023

SELL
$285.76 - $321.48 $23.2 Million - $26.1 Million
-81,147 Reduced 8.67%
854,908 $247 Million
Q3 2022

Oct 21, 2022

BUY
$273.83 - $305.53 $2.12 Million - $2.37 Million
7,748 Added 0.83%
936,055 $271 Million
Q2 2022

Jul 26, 2022

SELL
$234.96 - $292.55 $11.1 Million - $13.8 Million
-47,077 Reduced 4.83%
928,307 $262 Million
Q1 2022

Apr 27, 2022

SELL
$221.42 - $260.97 $14.3 Million - $16.8 Million
-64,362 Reduced 6.19%
975,384 $255 Million
Q4 2021

Feb 02, 2022

SELL
$177.01 - $223.45 $9.26 Million - $11.7 Million
-52,295 Reduced 4.79%
1,039,746 $228 Million
Q3 2021

Oct 25, 2021

SELL
$181.39 - $202.99 $4.86 Million - $5.44 Million
-26,817 Reduced 2.4%
1,092,041 $198 Million
Q2 2021

Aug 02, 2021

SELL
$187.49 - $221.1 $25.4 Million - $29.9 Million
-135,375 Reduced 10.79%
1,118,858 $226 Million
Q1 2021

Apr 30, 2021

SELL
$207.02 - $241.31 $6.97 Million - $8.12 Million
-33,649 Reduced 2.61%
1,254,233 $270 Million
Q4 2020

Feb 05, 2021

SELL
$207.01 - $276.09 $6.23 Million - $8.3 Million
-30,077 Reduced 2.28%
1,287,882 $304 Million
Q3 2020

Oct 30, 2020

SELL
$255.65 - $303.1 $4.22 Million - $5 Million
-16,501 Reduced 1.24%
1,317,959 $359 Million
Q2 2020

Jul 27, 2020

BUY
$225.48 - $295.8 $8.17 Million - $10.7 Million
36,251 Added 2.79%
1,334,460 $387 Million
Q1 2020

Apr 27, 2020

BUY
$199.77 - $247.81 $11.2 Million - $13.9 Million
56,113 Added 4.52%
1,298,209 $309 Million
Q4 2019

Jan 31, 2020

BUY
$166.71 - $223.91 $3.45 Million - $4.63 Million
20,672 Added 1.69%
1,242,096 $272 Million
Q3 2019

Oct 31, 2019

BUY
$166.23 - $187.09 $11.4 Million - $12.8 Million
68,293 Added 5.92%
1,221,424 $207 Million
Q2 2019

Jul 29, 2019

BUY
$164.61 - $190.37 $8.31 Million - $9.61 Million
50,477 Added 4.58%
1,153,131 $211 Million
Q1 2019

May 08, 2019

BUY
$163.73 - $194.7 $5.03 Million - $5.98 Million
30,705 Added 2.86%
1,102,654 $203 Million
Q4 2018

Feb 06, 2019

BUY
$151.91 - $192.21 $25 Million - $31.6 Million
164,403 Added 18.12%
1,071,949 $173 Million
Q3 2018

Nov 07, 2018

BUY
$167.73 - $192.74 $2.89 Million - $3.32 Million
17,232 Added 1.94%
907,546 $175 Million
Q2 2018

Aug 01, 2018

BUY
$145.72 - $169.96 $12.1 Million - $14.1 Million
83,121 Added 10.3%
890,314 $151 Million
Q1 2018

May 01, 2018

SELL
$151.6 - $177.13 $29,562 - $34,540
-195 Reduced 0.02%
807,193 $132 Million
Q4 2017

Feb 06, 2018

BUY
$137.28 - $155.55 $3.07 Million - $3.47 Million
22,338 Added 2.85%
807,388 $121 Million
Q3 2017

Nov 07, 2017

BUY
$148.13 - $162.24 $1.19 Million - $1.31 Million
8,064 Added 1.04%
785,050 $119 Million
Q2 2017

Aug 07, 2017

BUY
N/A
776,986
776,986 $100 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.